Treatment Options for Helicobacter Pylori Infection in the Elderly

Helicobacter pylori infection plays a key role in dyspepsia, peptic ulcer disease and gastric cancer, thus the eradication of the infection has become an important treatment goal in clinical practice. The aim of this review is to present indications and therapies that are relevant for the management...

Full description

Saved in:
Bibliographic Details
Published in:Aging health 2006-08, Vol.2 (4), p.661-668
Main Authors: Pilotto, Alberto, Franceschi, Marilisa, Perri, Francesco, Orsitto, Giuseppe, Di Mario, Francesco
Format: Article
Language:English
Subjects:
Aged
Antibacterial agents
Antiulcer drugs
Care and treatment
Helicobacter infections
Helicobacter pylori
Infection
Peptic ulcer
Stomach cancer
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Helicobacter pylori infection plays a key role in dyspepsia, peptic ulcer disease and gastric cancer, thus the eradication of the infection has become an important treatment goal in clinical practice. The aim of this review is to present indications and therapies that are relevant for the management of H. pylori infection in elderly patients. Effective antimicrobial therapy is available, although there is still no ideal treatment, and indications for therapy continue to evolve. One-week proton pump inhibitor-based triple therapies are very effective in elderly patients; moreover, low doses of antibiotics (clarithromycin) and proton pump inhibitors are probably sufficient to obtain excellent cure rates, reducing side effects and improving compliance in elderly subjects. In some elderly patients, 10-day sequential treatment may be considered. Prolonging triple therapies to 10-14 days or using bismuth-based quadruple therapies require further studies in elderly patients. Low compliance and antibiotic resistance are the main factors related to treatment failure in old age. Therapy for treatment failure may be improved by assessing antimicrobial sensitivity. New drugs and forms of administration have been reported, although their efficacy requires confirmation.
ISSN:1745-509X
1745-5103
DOI:10.2217/1745509X.2.4.661